Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Jun;15(2):166-74.
doi: 10.1002/wps.20309.

Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis

Davy Vancampfort  1   2 , Christoph U Correll  3   4 , Britta Galling  3 , Michel Probst  1 , Marc De Hert  2 , Philip B Ward  5 , Simon Rosenbaum  5 , Fiona Gaughran  6 , John Lally  6 , Brendon Stubbs  6   7   8
Affiliations

Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis

Davy Vancampfort et al. World Psychiatry. 2016 Jun.

Abstract

Type 2 diabetes mellitus (T2DM) is highly predictive of cardiovascular diseases and can have particularly deleterious health impacts in people with severe mental illness (SMI), i.e. schizophrenia, bipolar disorder or major depressive disorder. This meta-analysis aimed: a) to describe pooled frequencies of T2DM in people with SMI; b) to analyze the influence of demographic, illness and treatment variables as well as T2DM assessment methods; and c) to describe T2DM prevalence in studies directly comparing persons with each specific SMI diagnosis to general population samples. The trim and fill adjusted pooled T2DM prevalence among 438,245 people with SMI was 11.3% (95% CI: 10.0%-12.6%). In antipsychotic-naïve participants, the prevalence of T2DM was 2.9% (95% CI: 1.7%-4.8%). There were no significant diagnostic subgroup differences. A comparative meta-analysis established that multi-episode persons with SMI (N=133,470) were significantly more likely to have T2DM than matched controls (N=5,622,664): relative risk, RR=1.85, 95% CI: 1.45-2.37, p<0.001. The T2DM prevalence was consistently elevated in each of the three major diagnostic subgroups compared to matched controls. Higher T2DM prevalences were observed in women with SMI compared to men (RR=1.43, 95% CI: 1.20-1.69, p<0.001). Multi-episode (versus first-episode) status was the only significant predictor for T2DM in a multivariable meta-regression analysis (r(2) =0.52, p<0.001). The T2DM prevalence was higher in patients prescribed antipsychotics, except for aripriprazole and amisulpride. Routine screening and multidisciplinary management of T2DM is needed. T2DM risks of individual antipsychotic medications should be considered when making treatment choices.

Keywords: Diabetes mellitus; antipsychotics; bipolar disorder; major depressive disorder; schizophrenia; severe mental illness.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flow diagram for the search strategy. T2DM — type 2 diabetes mellitus, SMI — severe mental illness, CVD — cardiovascular disease
See this image and copyright information in PMC

References

    1. Chesney E, Goodwin GM, Fazel S. Risks of all‐cause and suicide mortality in mental disorders: a meta‐review. World Psychiatry 2014;13:153‐60. - PMC - PubMed
    1. Reininghaus U, Dutta R, Dazzan P et al. Mortality in schizophrenia and other psychoses: a 10‐year follow‐up of the AESOP first‐episode cohort. Schizophr Bull 2015;41:664‐73. - PMC - PubMed
    1. Chang CK, Hayes RD, Perera G et al. Life expectancy at birth for people with serious mental illness from a secondary mental health care case register in London, UK. PLoS One 2011;6:e19590. - PMC - PubMed
    1. Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ 2013;346:f2539. - PMC - PubMed
    1. Saha S, Chant D, McGrath J. A systematic review of mortality in schizophrenia. Arch Gen Psychiatry 2007;64:1123‐31. - PubMed

LinkOut - more resources